DiaMedica Therapeutics (DMAC) Institutional Ownership $4.02 -0.02 (-0.50%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)CurrentInstitutional OwnershipPercentage10.12%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.31MNumber ofInstitutional Sellers(last 12 months)0 Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DMAC Institutional Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! DiaMedica Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC306,958$1.29M0.0%+29.6%0.718% 11/15/2024 Point72 Asia Singapore Pte. Ltd.9,498$40K0.0%N/A0.022% 10/18/2024Blue Trust Inc.44,247$185K0.0%N/A0.104% 8/16/2024 Magnolia Capital Advisors LLC29,500$87K0.0%N/A0.069% 5/10/2024 Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670% 2/15/2024 Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318% Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/7/2024 Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033% 11/15/2023 Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053% 11/13/2023 EAM Investors LLC212,512$548K0.1%-21.4%0.560% 11/9/2023 Bleichroeder LP222,317$574K0.1%-24.4%0.586% 11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445% 8/30/2023 Cooperman Leon G875,993$3.78M0.2%+0.9%2.308% 8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738% 8/2/2023 Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135% 4/11/2023 Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095% 5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002% 2/15/2022 Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519% 11/15/2021 Marshall Wace LLP10,031$40K0.0%-93.6%0.053% 11/15/2021 Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454% 11/12/2021 Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882% 11/12/2021 Jump Financial LLC18,300$73K0.0%N/A0.097% 11/9/2021BlackRock Inc.55,970$225K0.0%-8.6%0.298% 8/25/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/16/2021 State Street Corp30,217$134K0.0%N/A0.161% 8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084% 8/16/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/13/2021 Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501% 8/13/2021 Geode Capital Management LLC133,569$594K0.0%+4.0%0.711% 8/13/2021 Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185% 8/12/2021 Trexquant Investment LP17,019$76K0.0%N/A0.091% 8/12/2021 Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075% 8/12/2021 JPMorgan Chase & Co.8,299$37K0.0%N/A0.044% 8/12/2021 Bank of Montreal Can142,846$694K0.0%+36.7%0.760% 5/21/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/19/2021 Squarepoint Ops LLC35,536$325K0.0%N/A0.189% 5/18/2021 Millennium Management LLC70,281$643K0.0%+72.0%0.374% 5/18/2021 Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940% 5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632% 5/18/2021 Citadel Advisors LLC20,601$189K0.0%N/A0.110% 5/13/2021 Barclays PLC3,412$31K0.0%N/A0.018% “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide!5/13/2021 Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815% 5/13/2021 Bank of New York Mellon Corp40,576$371K0.0%-5.4%0.216% 5/13/2021 Bank of Montreal Can104,524$982K0.0%+27.7%0.556% 5/12/2021 Northern Trust Corp85,026$778K0.0%-29.7%0.453% 5/12/2021 Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684% 5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981% 5/11/2021 EAM Investors LLC108,232$990K0.1%-1.6%0.576% 5/7/2021BlackRock Inc.60,165$551K0.0%+7.9%0.320% 4/27/2021 Dorsey Wright & Associates3,937$36K0.4%N/A0.021% 2/24/2021Virtu Financial LLC15,712$159K0.0%N/A0.084% 2/17/2021 Jane Street Group LLC12,537$127K0.0%N/A0.067% 2/16/2021 ExodusPoint Capital Management LP13,160$133K0.0%N/A0.070% 2/12/2021 Stonepine Capital Management LLC950,000$9.63M7.4%-17.1%5.070% 2/11/2021 Northern Trust Corp120,989$1.23M0.0%+3.6%0.646% 2/11/2021 Valeo Financial Advisors LLC5,000$51K0.0%N/A0.027% 2/10/2021 Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605% 2/9/2021 Bank of New York Mellon Corp42,905$435K0.0%+218.5%0.229% 2/6/2021Granite Point Capital Management L.P.546,855$5.55M0.3%-15.5%2.918% 2/5/2021BlackRock Inc.55,781$566K0.0%+27.4%0.298% 11/17/2020 Nantahala Capital Management LLC756,193$3.21M0.1%+0.8%4.035% 11/16/2020 Point72 Asset Management L.P.800,000$3.39M0.0%N/A4.269% 11/16/2020 Worth Venture Partners LLC42,887$182K0.1%N/A0.229% 11/16/2020 Manatuck Hill Partners LLC571,500$2.42M1.1%+62.8%3.050% 11/16/2020 Boothbay Fund Management LLC46,562$197K0.0%N/A0.248% 11/13/2020 Stonepine Capital Management LLC1,146,470$4.86M5.1%+71.5%6.118% 11/13/2020 Morgan Stanley9,100$38K0.0%+56.9%0.049% (Data available from 1/1/2016 forward) DMAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMAC shares? During the previous two years, 13 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($1.42M), Geode Capital Management LLC ($1.29M), Bleichroeder LP ($574K), EAM Investors LLC ($548K), and Jacob Asset Management of New York LLC ($435K).Learn more on DMAC's institutional investors. What percentage of DiaMedica Therapeutics stock is owned by institutional investors? 10.12% of DiaMedica Therapeutics stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings. Which institutional investors have been buying DiaMedica Therapeutics stock? Of the 10 institutional investors that purchased DiaMedica Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($211.35K), Geode Capital Management LLC ($70.07K), Blue Trust Inc. ($44.25K), Paragon Associates & Paragon Associates II Joint Venture ($30K), Magnolia Capital Advisors LLC ($29.50K), Catalyst Financial Partners LLC ($21.79K), and Stonebridge Capital Advisors LLC ($20K). How much institutional buying is happening at DiaMedica Therapeutics? Institutional investors have bought a total of 456,538 shares in the last 24 months. This purchase volume represents approximately $1.48M in transactions. Which DiaMedica Therapeutics major shareholders have been selling company stock? The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: Bleichroeder LP ($71.80K), Jacob Asset Management of New York LLC ($65K), and EAM Investors LLC ($57.91K). How much institutional selling is happening at DiaMedica Therapeutics? Institutional investors have sold a total of 194,707 shares in the last 24 months. This volume of shares sold represents approximately $563.24K in transactions. Related Companies Ironwood Pharmaceuticals Major Shareholders Entrada Therapeutics Major Shareholders Pharvaris Major Shareholders Arbutus Biopharma Major Shareholders CorMedix Major Shareholders Tectonic Therapeutic Major Shareholders Exscientia Major Shareholders AnaptysBio Major Shareholders ORIC Pharmaceuticals Major Shareholders Dianthus Therapeutics Major Shareholders This page (NASDAQ:DMAC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
